SpliSense
PrivateLast Round
Grant
Jun 16, 2026
Total Funding Raised
$51.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SpliSense operates in Healthcare & Life Sciences and is based in Jerusalem. Its latest recorded funding round was a Grant round in June 2026.
SpliSense is a biotechnology company that develops innovative RNA-based therapies using antisense oligonucleotides to treat cystic fibrosis and other genetic pulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpliSense Comparables
Compare SpliSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aceso Therapeutics | 88% | |
| Spirovant Sciences | 87% | |
| ReCode Therapeutics | 86% |
For institutional investors. Book with your work email.
SpliSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2026 | ||||
| Grant | Apr 3, 2024 | ||||
| Series B | May 13, 2021 | ||||
| Series A | Nov 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpliSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Series B, Grant |
| OrbiMed | Grant, Series B |
| Integra Holdings | Series B, Series A, Grant |
| Cystic Fibrosis Foundation | Series B, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 40% MoM.
- Jul 25, 2026
Monthly visitors increased 90% MoM.
For institutional investors. Book with your work email.
SpliSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpliSense's valuation, stock price, and market status.
Is SpliSense a public or private company?
SpliSense is a private company.
What is the current stock price of SpliSense?
SpliSense is a private company, so its shares have no public market price. Caplight tracks SpliSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpliSense worth (valuation)?
Valuation information for SpliSense is not publicly available.
Can I buy SpliSense stock?
SpliSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpliSense's last funding round?
SpliSense's most recent funding round was Grant on June 16, 2026.
Who are the main investors in SpliSense?
Key investors in SpliSense include OrbiMed, Cystic Fibrosis Foundation.
Will SpliSense IPO soon?
No public IPO plans have been announced for SpliSense.
How can I track SpliSense secondary market activity?
Caplight tracks bids, offers, and trades in SpliSense's shares on secondary markets.